I

Ipsen Global

Global biopharma focused on specialty care

Head of Commercial Operations & Strategic Initiatives - Rare Disease

Business OperationsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAHybrid

About the Job

Requirements

  • At least 12 years of related experience with a bachelor's degree, or 8 years with a master's degree, or equivalent experience.
  • Demonstrated success serving as a senior advisor to business-unit or enterprise leadership and leading through influence across complex matrixed organizations.
  • Proven accountability for integrated business planning, governance, performance management, and execution of enterprise-level strategic priorities.
  • Experience building and leading high-performing teams, including direct people-management responsibility and leadership of cross-functional teams.
  • Demonstrated ability to synthesize complex market, customer, financial, and operational information into clear executive recommendations and decisions.
  • Experience leading organizational transformation, operating-model change, or capability-building initiatives with measurable business impact.
  • Strong commercial and financial acumen, including resource prioritization, investment evaluation, key performance indicator development, and performance management.
  • Strong communication and interpersonal skills and the ability to influence others.
  • Ability to work in a hybrid model, including in-office work multiple times per week from the Cambridge, Massachusetts headquarters.
  • Willingness and ability to travel domestically; international travel may be required.
  • A Bachelor of Arts or Bachelor of Science degree is required.

Responsibilities

  • Serve as strategic advisor and Chief of Staff to the Senior Vice President, shaping the Rare Disease Business Unit agenda, framing critical business decisions, anticipating enterprise risks and opportunities, and driving Leadership Team effectiveness and accountability.
  • Design and lead the Rare Disease Business Unit governance and management operating system, including Leadership Team forums, operating reviews, executive and board communications, decision processes, and accountability mechanisms.
  • Partner with the Rare Disease Business Unit Leadership Team to define objectives, shape culture, and drive alignment with cross-functional teams.
  • Own the integrated Rare Disease Business Unit planning process, aligning strategic, brand, operational, workforce, and financial plans; identifying interdependencies and trade-offs; and ensuring resources are directed to the highest-value priorities.
  • Serve as the Rare Disease Business Unit champion and expert for key account management, building operating mechanisms and organizational capabilities that accelerate product adoption in priority health systems.
  • Identify organizational capabilities and operating-model enhancements that accelerate portfolio growth and long-term success.
  • Build, lead, and develop a high-performing Commercial Operations and Strategic Initiatives team of 2–3 people, establishing clear accountabilities, strengthening capabilities, and creating succession and development plans.
  • Drive strategic and operational excellence by identifying, exploring, and implementing innovative commercial capabilities.
  • Oversee performance monitoring, recognition programs, and continuous improvement efforts.
  • Own the Rare Disease Business Unit performance-management framework in partnership with Business Operations & Strategy, including key performance indicators, leading and lagging indicators, dashboards, business insights, and executive reporting that enable timely decisions and corrective action.
  • Provide strategic leadership and Rare Disease Business Unit business ownership for sales operations capabilities, including targeting, segmentation, territory design, incentive effectiveness, customer relationship management adoption, field-force analytics, and performance reporting, in partnership with Business Operations & Strategy and field leadership.
  • Lead enterprise-wide launch readiness and commercialization planning for the Rare Disease Business Unit, establishing governance, integrated workplans, decision milestones, risk mitigation, and executive-level progress reporting.
  • Set the operational excellence agenda for the Rare Disease Business Unit, leading enterprise-wide process redesign, operating-model improvements, and capability investments that remove barriers, increase organizational agility, and improve business performance.
  • Translate market, customer, and performance insights into strategic recommendations that improve business outcomes.
  • Build and lead a Health System Account team responsible for Rare Disease Business Unit priority account strategic planning and execution to enhance patient diagnosis and treatment pathways, referral and care coordination, and access to Rare Disease Business Unit treatments.
  • Lead operating-model and capability transformation across the Rare Disease Business Unit, identifying and implementing the organizational, process, technology, and insight capabilities required to support portfolio growth.
  • Build alignment among senior cross-functional leaders, resolve competing priorities, and create conditions for timely enterprise decisions and coordinated execution.

Desired Qualifications

  • An MBA is strongly preferred.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs